Siplizumab

From Self-sufficiency
Jump to: navigation, search
Siplizumab
Monoclonal antibody
Type Whole antibody
Source Template:Infobox drug/mab source
Target CD2
Identifiers
CAS Number 288392-69-8
ATC code none
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Siplizumab (MEDI-507) is a novel monoclonal antibody with a human IgG1, kappa directed to CD2. The agent has shown potent immunomodulatory effects, selectively suppressing the function of T and NK cells, and is currently being tested as a possible treatment for psoriasis and in the prevention of graft-versus-host disease.[1]

References

  1. ClinicalTrials.gov